ADIA · Adia Nutrition, Inc.

Adia Nutrition reported Q1 FY2026 revenue of $176.3K, generating $67.6K gross profit at a 38.3% margin that reflects underlying production efficiencies in its biologics and procedures mix. This topline reflects management's focus on growth, though the period's -$151.9K operating income—equating to an -86.2% margin—highlights expenses outstripping gains as the company scales post-pivot. The resulting net loss of -$162.5K with $0.00 diluted EPS underscores the early-stage dynamics where gross profit alone cannot yet cover full costs, prompting reliance on external capital as noted in liquidity discussions.

Cash flow from operations used -$55.0K, leading to -$60.5K free cash flow after $5.5K in capital expenditures likely supporting equipment for expanded capacity. This burn aligns with management's outlook on utilizing the line-of-credit facility—extended by a related party for working capital—and pursuing additional funding for receivables financing and operating needs. Prior-period changes like inventory increases and prepaid decreases illustrate ongoing working capital volatility that contributes to cash strain, even as short-term financial instruments carry values approximating fair values.